| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Korsana Biosciences, Inc.
13G
KRSA · 23255M303
|
5.2% |
11/16/2026
Event 9/30/2026
|
|||
|
Blossomhill Therapeutics, Inc.
13G
BLSM · 095130100
|
7.8% |
11/16/2026
Event 9/30/2026
|
|||
|
Titan Machinery Inc.
13G
TITN · 88830R101
|
5.0% |
11/16/2026
Event 9/30/2026
|
|||
|
Napco Security Technologies, Inc.
13G
NSSC · 630402105
|
5.1% |
11/16/2026
Event 9/30/2026
|
|||
|
Anterix Inc.
13G
ATEX · 03676C100
|
5.3% |
11/16/2026
Event 9/30/2026
|
|||
|
Definium Therapeutics, Inc.
13G
DFTX · 24477V105
|
5.4% |
11/16/2026
Event 9/30/2026
|
|||
|
Central Garden & Pet Co
13G
CENT · 153527106
|
7.3% |
11/16/2026
Event 9/30/2026
|
|||
|
Newamsterdam Pharma N.V.
13G
NAMS · N62509109
|
7.5% |
11/16/2026
Event 9/30/2026
|
|||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 1
TENX · 88032L605
|
0% |
11/16/2026
Event 9/30/2026
|
|||
|
Protara Therapeutics, Inc.
13G/A
Amendment 8
TARA · 74365U107
|
0% |
11/16/2026
Event 9/30/2026
|
|||
|
Longeveron Inc.
13G/A
Amendment 1
LGVN · 54303L203
|
4.4% |
11/16/2026
Event 9/30/2026
|
|||
|
Ligand Pharmaceuticals Incorporated
13G/A
Amendment 10
LGND · 53220K504
|
4.6% |
11/16/2026
Event 9/30/2026
|
|||
|
Assembly Biosciences, Inc.
13G/A
Amendment 2
ASMB · 045396207
|
3.3% |
11/16/2026
Event 9/30/2026
|
|||
|
Collegium Pharmaceutical, Inc.
13G/A
Amendment 1
COLL · 19459J104
|
0.2% |
11/16/2026
Event 9/30/2026
|
|||
|
Biohaven Ltd.
13G/A
Amendment 4
BHVN · G1110E107
|
1.4% |
11/16/2026
Event 9/30/2026
|
|||
|
Yarrow Bioscience, Inc.
13G/A
Amendment 1
YARW · 92941V407
|
3.0% |
11/16/2026
Event 9/30/2026
|
|||
|
Rentokil Initial PLC
13G/A
Amendment 5
RKLIF · G7494G105
|
3.3% |
11/16/2026
Event 9/30/2026
|
|||
|
Revolution Medicines, Inc.
13G/A
Amendment 1
RVMD · 76155X100
|
3.5% |
11/16/2026
Event 9/30/2026
|
|||
|
DraftKings Inc.
13G/A
Amendment 1
DKNG · 26142V105
|
4.2% |
11/16/2026
Event 9/30/2026
|
|||
|
Lantheus Holdings, Inc.
13G/A
Amendment 9
LNTH · 516544103
|
4.2% |
11/16/2026
Event 9/30/2026
|
|||
|
Contineum Therapeutics, Inc.
13G/A
Amendment 1
CTNM · 21217B100
|
4.6% |
11/16/2026
Event 9/30/2026
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 11
MIRM · 604749101
|
8.5% |
11/16/2026
Event 9/30/2026
|
|||
|
Monopar Therapeutics Inc.
13G/A
Amendment 5
MNPR · 61023L207
|
16.7% |
11/16/2026
Event 9/30/2026
|
|||
|
Lexeo Therapeutics, Inc.
13G/A
Amendment 8
LXEO · 52886X107
|
7.2% |
11/16/2026
Event 9/30/2026
|
|||
|
Revvity, Inc.
13G/A
Amendment 3
RVTY · 714046109
|
6.6% |
11/16/2026
Event 9/30/2026
|
|||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 1
EWTX · 28036F105
|
6.7% |
11/16/2026
Event 9/30/2026
|
|||
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 3
OLMA · 68062P106
|
7.2% |
11/16/2026
Event 9/30/2026
|
|||
|
Glaukos Corp
13G/A
Amendment 2
GKOS · 377322102
|
7.9% |
11/16/2026
Event 9/30/2026
|
|||
|
WEX, Inc.
13G/A
Amendment 13
WEX · 96208T104
|
8.6% |
11/16/2026
Event 9/30/2026
|
|||
|
Surgery Partners, Inc.
13G/A
Amendment 4
SGRY · 86881A100
|
4.9% |
11/6/2026
Event 10/30/2026
|
|||
|
Eyepoint, Inc.
13G
EYPT · 30233G209
|
10.9% |
9/8/2026
Event 8/31/2026
|
|||
|
Vogenx, Inc.
13G
VOGX · 92859A106
|
13.0% |
9/8/2026
Event 8/31/2026
|
|||
|
Teleflex Incorporated
13G/A
Amendment 6
TFX · 879369106
|
10.3% |
9/8/2026
Event 8/31/2026
|
|||
| JANUS HENDERSON GROUP Ltd. | 10.3% | ||||
| Janus Henderson Enterprise Fund | 6.8% | ||||
|
Ziff Davis, Inc.
13G/A
Amendment 9
ZD · 48123V102
|
10.3% |
9/8/2026
Event 8/31/2026
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 10
MIRM · 604749101
|
9.7% |
8/13/2026
Event 6/30/2026
|
|||
|
Forte Biosciences, Inc.
13G/A
Amendment 5
FBRX · 34962G208
|
9.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Assembly Biosciences, Inc.
13G/A
Amendment 1
ASMB · 045396207
|
6.9% |
8/13/2026
Event 6/30/2026
|
|||
|
Tarsus Pharmaceuticals, Inc.
13G/A
Amendment 1
TARS · 87650L103
|
6.5% |
8/13/2026
Event 6/30/2026
|
|||
|
Dyne Therapeutics, Inc.
13G/A
Amendment 7
DYN · 26818M108
|
7.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Protara Therapeutics, Inc.
13G/A
Amendment 7
TARA · 74365U107
|
8.4% |
8/13/2026
Event 6/30/2026
|
|||
|
Ziff Davis, Inc.
13G/A
Amendment 8
ZD · 48123V102
|
9.7% |
8/13/2026
Event 6/30/2026
|
|||
|
ICU Medical, Inc.
13G/A
Amendment 12
ICUI · 44930G107
|
11.1% |
8/13/2026
Event 6/30/2026
|
|||
|
Immix Biopharma, Inc.
13G/A
Amendment 3
IMMX · 45258H106
|
14.0% |
8/13/2026
Event 6/30/2026
|
|||
|
Janux Therapeutics, Inc.
13G/A
Amendment 6
JANX · 47103J105
|
0.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Flex Ltd.
13G/A
Amendment 8
FLEX · Y2573F102
|
3.8% |
8/13/2026
Event 6/30/2026
|
|||
|
Bicara Therapeutics Inc.
13G/A
Amendment 1
BCAX · 055477103
|
4.8% |
8/13/2026
Event 6/30/2026
|
|||
|
Bel Fuse Inc.
13G/A
Amendment 2
BELFB · 077347300
|
4.8% |
8/13/2026
Event 6/30/2026
|
|||
|
Ocugen, Inc.
13G/A
Amendment 1
OCGN · 67577C105
|
3.0% |
8/13/2026
Event 6/30/2026
|
|||
|
Revolution Medicines, Inc.
13G
RVMD · 76155X100
|
5.1% |
8/13/2026
Event 6/30/2026
|
|||
|
Achieve Life Sciences, Inc.
13G
ACHV · 004468500
|
5.4% |
8/13/2026
Event 6/30/2026
|
|||
|
Inspired Entertainment, Inc.
13G
INSE · 45782N108
|
5.0% |
8/13/2026
Event 6/30/2026
|
|||
|
LPL Financial Holdings Inc.
13G
LPLA · 50212V100
|
5.3% |
8/13/2026
Event 6/30/2026
|
|||
|
OSI Systems, Inc.
13G
OSIS · 671044105
|
5.5% |
8/13/2026
Event 6/30/2026
|
|||
|
Jatt II Acquisition Corp.
13G
JATT · G50765109
|
6.2% |
8/13/2026
Event 6/30/2026
|
|||
|
Vaxcyte, Inc.
13G/A
Amendment 11
PCVX · 92243G108
|
12.1% |
8/11/2026
Event 7/31/2026
|
|||
|
Yarrow Bioscience, Inc.
13G
YARW · 92941V407
|
10.0% |
8/7/2026
Event 7/31/2026
|
|||
|
Vaxcyte, Inc.
13G/A
Amendment 10
PCVX · 92243G108
|
0.1% |
8/7/2026
Event 7/31/2026
|
|||
|
Forte Biosciences, Inc.
13G/A
Amendment 6
FBRX · 34962G208
|
2.5% |
8/7/2026
Event 7/31/2026
|
|||
|
Privacore VPC Asset Backed Credit Fund
13G
74291E300
|
17.1% |
7/8/2026
Event 6/30/2026
|
|||
|
Privacore Pcaam Alternative Growth Fund
13G
74290Y307
|
46.8% |
7/8/2026
Event 6/30/2026
|
|||
|
Privacore Pcaam Alternative Income Fund
13G
74291A308
|
67.4% |
7/8/2026
Event 6/30/2026
|
|||
|
Biohaven Ltd.
13G/A
Amendment 2
BHVN · G1110E107
|
5.7% |
7/8/2026
Event 6/30/2026
|
|||
|
Jade Biosciences, Inc.
13G/A
Amendment 2
JBIO · 008064206
|
10.6% |
7/8/2026
Event 6/30/2026
|
|||
|
Cellectar Biosciences, Inc.
13G
CLRB · 15117F880
|
10.0% |
6/5/2026
Event 5/29/2026
|
|||
|
Immix Biopharma, Inc.
13G/A
Amendment 2
IMMX · 45258H106
|
13.0% |
6/5/2026
Event 5/29/2026
|
|||
|
Tyra Biosciences, Inc.
13G/A
Amendment 2
TYRA · 90240B106
|
7.2% |
5/15/2026
Event 3/31/2026
|
|||
|
PTC Therapeutics, Inc.
13G/A
Amendment 1
PTCT · 69366J200
|
8.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Protara Therapeutics, Inc.
13G/A
Amendment 6
TARA · 74365U107
|
9.6% |
5/15/2026
Event 3/31/2026
|
|||
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 2
OLMA · 68062P106
|
8.2% |
5/15/2026
Event 3/31/2026
|
|||
|
Lantheus Holdings, Inc.
13G/A
Amendment 8
LNTH · 516544103
|
7.4% |
5/15/2026
Event 3/31/2026
|
|||
|
Janux Therapeutics, Inc.
13G/A
Amendment 5
JANX · 47103J105
|
6.9% |
5/15/2026
Event 3/31/2026
|
|||
|
Jade Biosciences, Inc.
13G/A
Amendment 1
JBIO · 008064206
|
6.3% |
5/15/2026
Event 3/31/2026
|
|||
|
Immix Biopharma, Inc.
13G/A
Amendment 1
IMMX · 45258H106
|
9.1% |
5/15/2026
Event 3/31/2026
|
|||
|
Vaxcyte, Inc.
13G/A
Amendment 9
PCVX · 92243G108
|
11.5% |
5/15/2026
Event 3/31/2026
|
|||
|
Maze Therapeutics, Inc.
13G/A
Amendment 3
MAZE · 578784100
|
5.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Madrigal Pharmaceuticals, Inc.
13G/A
Amendment 9
MDGL · 558868105
|
8.8% |
5/15/2026
Event 3/31/2026
|
|||
|
IDEAYA Biosciences, Inc.
13G/A
Amendment 6
IDYA · 45166A102
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
|
Biohaven Ltd.
13G/A
Amendment 2
BHVN · G1110E107
|
11.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Glaukos Corp
13G/A
Amendment 1
GKOS · 377322102
|
9.2% |
5/15/2026
Event 3/31/2026
|
|||
|
Gildan Activewear Inc
13G/A
Amendment 4
GIL · 375916103
|
5.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Forte Biosciences, Inc.
13G/A
Amendment 4
FBRX · 34962G208
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
|
Dyne Therapeutics, Inc.
13G/A
Amendment 6
DYN · 26818M108
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 4
DRUG · 10919W405
|
13.1% |
5/15/2026
Event 3/31/2026
|
|||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 4
DRUG · 10919W405
|
13.1% |
5/15/2026
Event 3/31/2026
|
|||
|
BridgeBio Pharma, Inc.
13G/A
Amendment 1
BBIO · 10806X102
|
6.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Bel Fuse Inc.
13G/A
Amendment 1
BELFB · 077347300
|
7.2% |
5/15/2026
Event 3/31/2026
|
|||
|
Ascendis Pharma A/S
13G/A
Amendment 9
ASND · 04351P101
|
6.0% |
5/15/2026
Event 3/31/2026
|
|||
|
Minerva Neurosciences, Inc
13G
NERV · 603380205
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
|
Longeveron Inc.
13G
LGVN · 54303L203
|
5.9% |
5/15/2026
Event 3/31/2026
|
|||
|
Bicara Therapeutics Inc.
13G
BCAX · 055477103
|
5.1% |
5/15/2026
Event 3/31/2026
|
|||
|
Tarsus Pharmaceuticals, Inc.
13G
TARS · 87650L103
|
5.3% |
5/15/2026
Event 3/31/2026
|
|||
|
Stride, Inc.
13G
LRN · 86333M108
|
5.4% |
5/15/2026
Event 3/31/2026
|
|||
|
Edgewise Therapeutics, Inc.
13G
EWTX · 28036F105
|
5.5% |
5/15/2026
Event 3/31/2026
|
|||
|
Collegium Pharmaceutical, Inc.
13G
COLL · 19459J104
|
5.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Dayforce, Inc.
13G/A
Amendment 2
DAY · 15677J108
|
0% |
5/15/2026
Event 3/31/2026
|
|||
|
Ardelyx, Inc.
13G/A
Amendment 9
ARDX · 039697107
|
3.4% |
5/15/2026
Event 3/31/2026
|
|||
|
OSI Systems, Inc.
13G/A
Amendment 13
OSIS · 671044105
|
4.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Revolution Medicines, Inc.
13G/A
Amendment 4
RVMD · 76155X100
|
4.9% |
5/15/2026
Event 3/31/2026
|
|||
|
Xenon Pharmaceuticals Inc.
13G/A
Amendment 1
XENE · 98420N105
|
4.5% |
5/15/2026
Event 3/31/2026
|
|||
|
SS&C Technologies Holdings, Inc
13G/A
Amendment 14
SSNC · 78467J100
|
3.5% |
5/15/2026
Event 3/31/2026
|
|||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.